Immunology articles for Japan

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 105

Article ‘Count’ for Immunology.

Journal Count Share
1 0.03
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (‘Registry’) 0.03
2 0.95
Diagnostic implications and correlates of plasma ADA2 activity and ADA2 variants 0.01
Prognostic value of lupus anticoagulant and anti‐β2 glycoprotein I antibody in adverse pregnancy outcomes. 0.94
3 0.23
Targeting donor XCR1+ and CD11b+ dendritic cells prevents Th1- and Th17-dependent GVHD within the gastrointestinal tract 0.06
RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT 0.13
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study 0.03
2 1.04
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis 0.04
CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica 1.00
1 0.08
Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective niche 0.08
2 1.03
Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells 0.96
Targeting Interactions Between Siglec-10 and α3β1 Integrin Enhances Macrophage-Mediated Phagocytosis of Pancreatic Cancer. 0.07
2 0.11
In vivo detection of immune responses via cytokine activity labeling 0.05
Mucosal viral infection elicits long-lived IgA responses via type 1 follicular helper T cells 0.06
2 0.10
Microbiota utilization of intestinal amino acids modulates cancer progression and anticancer immunity 0.05
Age-related impairment of intestinal inflammation resolution through an eicosanoid-immune-microbiota axis 0.05
1 0.02
HEV-Targeted Antibody-Drug Conjugate Promotes Long-Term Cardiac Allograft Acceptance. 0.02
1 0.13
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18–64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8 0.13
1 1.00
Macrophages promote tumor growth by phagocytosis-mediated cytokine amplification in Drosophila 1.00
1 1.00
Rapid and Slow Progressors Toward β-Cell Depletion and Their Predictors in Type 1 Diabetes: Prospective Longitudinal Study in Japanese Type 1 Diabetes (TIDE-J). 1.00
1 0.10
Retraction notice to ‘T-2 toxin induces dermal inflammation and toxicity in mice: The healing potential of menthol’ [Environ. Res. 228 (2023) 115838] 0.10
4 2.20
Foxp3 and BATF cooperatively direct cis-regulatory programs and gene expression for effector Treg cell differentiation 1.00
A hierarchical Rorc(γt) cis-regulatory cascade orchestrates differentiation of RORγt⁺ innate immune cells 1.00
A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria 0.18
Myeloid cells mediate interferon-driven resistance to immunotherapy in advanced renal cell carcinoma 0.03
6 6.00
Molecular Basis of Fibrinogen Recognition by the Innate Immune Receptor LILRA2 1.00
High-density lipoprotein mediates silica nanoparticle recognition by the multi-ligand receptor SR-B1 1.00
Lipopeptide ligands captured by MHC class I molecules undergo dynamic conformational changes that affect their antigenic strength 1.00
Extravesicular Chloride Ion Regulates the Uptake of ATP, Sulfate, and Inorganic Phosphate by Membrane Vesicles from Bovine Adrenal Chromaffin Granules 1.00
Molecular basis of IFN-γ–induced STAT3 phosphorylation stimulated by Sendai virus C protein 1.00
Nitric oxide regulates phagocytosis through S-nitrosylation of Rab5 1.00
4 2.12
Lysophosphatidic acid-mediated NF-κB activation promotes FOXC2 expression essential for lymphatic valve development 1.00
Selective disruption of RORγt-CBFβ interaction by IMU-935 prevents RORγt-dependent Th17 autoimmunity but not thymocyte development 0.05
CD300a immunoreceptor regulates ischemic tissue damage and adverse remodeling in the mouse heart and kidney 1.00
LAG3 regulates antibody responses in a murine model of kidney transplantation 0.06
10 6.22
Claudin 1–mediated positioning of DC1 to mTECs is essential for maintenance of central tolerance 0.04
DOCK8 and STAT3 cooperate to restrain IgE-inducing T follicular helper cells 0.04
The antigen-presenting molecule MR1 binds host-generated riboflavin catabolites 0.18
Chimeric MHC class I– and II–restricted non-self epitopes broaden antitumor T cell reactions 0.81
Notch interaction with RUNX factors regulates initiation of the T-lineage program 0.96
Oral antigen exposure under costimulation blockade induces Treg cells to establish immune tolerance 1.00
Invariant TCR-triggered protein kinase D activation mediates NKT cell development 1.00
Multi-omics uncovers transcriptional programs of gut-resident memory CD4+ T cells in Crohn’s disease 1.00
The STING pathway drives noninflammatory neurodegeneration in NGLY1 deficiency 0.19
KLF2 expression in IgG plasma cells at their induction site regulates the migration program 1.00
1 1.00
iPrevotella intermedia/i Synergistically Exacerbates Pneumonia Induced by Oral Streptococci 1.00
1 1.00
Glutathione Synthesis via the Cystine/Glutamate Transporter Promotes the Formation of Tertiary Lymphoid Structures in the Kidney. 1.00
1 1.00
Molecular mechanism of MDA5 nucleation and filament formation by LGP2 1.00
2 0.48
Human gut M cells resemble dendritic cells and present gluten antigen 0.15
RIFINs displayed on malaria-infected erythrocytes bind KIR2DL1 and KIR2DS1 0.33
19 11.95
Structural Mechanism of Receptor-Triggered MyD88 Oligomeric Assembly in Innate Immune Signaling 1.00
The CD4+ T cell population partners with Tpex CD8+ T cells to mediate antitumor immunity in the tumor microenvironment 1.00
cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis 1.00
Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer 1.00
Acute peritonitis-induced adipose CD127 ILC1s express PD-L1 and ameliorate inflammation in mice 0.80
APIP regulates the priming of canonical NLRP3 and non-canonical Caspase-11/4 inflammasomes by binding to TRAF6 0.57
Deleterious variants in the autophagy-related gene /FIP200 impair immunity to SARS-CoV-2 0.03
GPR43 in eosinophils suppresses the emergence of pathogenic Siglec-Fhi neutrophils in allergic airway inflammation in mice 0.11
Reconstruction of the lymphatic system by transplantation of a centrifuge-based bioengineered lymphatic tissue 1.00
Molecular basis for selection and inhibition of HIV-1 escape virus by T cells and KIR2DL2NK cells 0.72
Stage-specific roles of clonally expanded CD8+ T cells in regulating amyloid pathology in Alzheimer’s disease models 1.00
A pan-immunotherapy signature to predict intratumoral CD8+ T cell expansions 0.74
Molecular basis of potent antiviral HLA-C-restricted CD8 T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope 0.81
SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adults 0.07
Regulatory T cell therapy promotes TGF-β and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2 0.05
Intestinal CD4−CD8αβ−TCRαβ+ T cells function as tolerogenic antigen presenting cells in mice 0.91
Small intestinal γδ T17 cells promote SAE through STING/C1q-induced microglial synaptic pruning in male mice 0.06
Type 1 innate lymphoid cell–immature neutrophil axis suppresses acute tissue inflammation 1.00
CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth 0.08
6 2.82
Tissue-restricted secondary TCR engagement drives the transition from stem-like to CD200 Egr2 arthritogenic Th17 cells 0.82
Phosphorylation of Runx protein controls helper CD4+ T cell versus cytotoxic CD8+ T cell lineage choice 0.94
2′--Methyl-guanosine RNA fragments antagonize TLR7 and TLR8 to limit autoimmunity 0.09
Single-cell analysis reveals cell death as driver of NLRP3-mediated secretion of IL-1β in human monocytes 0.71
Simultaneous STING and lymphotoxin-β receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity 0.17
Migrating immune cells globally coordinate protrusive forces 0.08
1 0.04
Pig-to-human lung xenotransplantation into a brain-dead recipient 0.04
1 1.00
Disrupting CD22-cis-ligand interactions ameliorates type 1 diabetes and graft rejection by expanding regulatory B cells 1.00
1 1.00
Immunogenicity and safety of DS-5670d, an omicron XBB.1.5-targeting COVID-19 mRNA vaccine: A phase 3, randomized, active-controlled study 1.00
7 5.09
R-loop disruption triggers irreversible topoisomerase 1–DNA cleavage complex formation during AID-dependent IgH gene diversification 1.00
Constitutively high levels of endogenous soluble ST2 inhibit food allergic responses in mice 1.00
Prostaglandin E2-EP2/EP4 signaling induces the tumor-infiltrating Treg phenotype for tumor growth 1.00
Stress-induced organismal death is genetically regulated by the mTOR–Zeste–Phae1 axis 1.00
HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes 0.08
Tumor-expressed GPNMB orchestrates Siglec-9+ TAM polarization and EMT to promote metastasis in triple-negative breast cancer 0.98
Induction of the ISR by AB5 subtilase cytotoxin drives type-I IFN expression in pDCs via STING activation 0.03
2 1.97
<atl>Hepatic leukemia factor directs tissue residency of proinflammatory memory CD4 sup+/sup T cells</atl> 0.97
Membrane topology inversion of GGCX mediates cytoplasmic carboxylation for antiviral defense 1.00
6 4.00
CD69 regulates the tissue dynamics of epigenetically imprinted memory CD4+ T cells 0.95
Pathogenic GM-CSF drives functional diversification of inflammatory macrophages in autoimmune arthritis 0.81
Persistent antigen is essential for sustaining Leishmania major–specific memory CD4+ T cells and long-term immunity 0.15
Human precursor T follicular regulatory cells are primed for differentiation into mature Tfr and disrupted during severe infections 1.00
Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems 0.08
Diverse developmental pathways of lymphoid conventional dendritic cells with distinct tissue distribution and function 1.00
3 1.98
Conversion of pathogenic T cells into functionally stabilized Treg cells for antigen-specific immunosuppression in pemphigus vulgaris 1.00
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection 0.97
An mRNA-based broad-spectrum antiviral inspired by ISG15 deficiency protects against viral infections in vitro and in vivo 0.01
2 1.06
Shigella type-III secretion system effectors counteract the induction of host inflammation and cell death. 1.00
Cardiolipin inhibits the non-canonical inflammasome by preventing LPS binding to caspase-4/11. 0.06
3 1.56
Hereditary Angioedema iPSC Models Implicate ER-Associated Degradation as a Potential Therapeutic Target 0.79
A clinically validated assay for rapid determination of type I and type II interferon activity in systemic inflammatory diseases 0.02
Fabs targeting a Cε2 epitope disassemble IgE-receptor complexes and suppress anaphylaxis 0.75
4 0.22
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia 0.08
Iptacopan in IgA Nephropathy — Final 24-Month Data 0.03
Ianalumab plus Eltrombopag in Immune Thrombocytopenia 0.08
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN 0.03
1 0.03
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial 0.03

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.